Akso Health Group
NASDAQ:AHGFinancial - Credit Services
+$0.03 today
- Market cap
- $1.16B
- Beta
- -1.02
- P/E (TTM)
- -3.1
- EPS (TTM)
- -$0.40
Volume 0.00M
Average 0.12M
AHG Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Akso Health GroupNASDAQ: AHG
Selling, General & Admin · Q4 FY2025 · quarter ended Mar 2025
Selling, general & admin declines year over year
Q4 FY2025 selling, general & admin of $1.45M fell 54.6% year over year, ahead of the -58.4% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +6.0% a year.
Context
- Selling, general & admin amounted to 24.6% of revenue in FY2025, down 338.2 pp from a year earlier.
- Selling, general & admin increased in 1 of the last 3 fiscal years.
What to watch
Whether selling, general & admin reaches the consensus estimate from 1 analysts of $126.73M (+3380.3%) for the fiscal year ending Mar 2026, a step up from the -58.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2025
- $1.45M+0.0% QoQ
- Last fiscal yearMar 2025
- $3.64M-58.4% YoY
- LTMMar 2025
- $3.64M-58.4% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 3.64M USD
- Year-over-year change
- -58.4%
- 4-year CAGR
- +14.9%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-03-31 | 3.64M | -58.4% |
| FY2024 | 2024-03-31 | 8.76M | -43.6% |
| FY2023 | 2023-03-31 | 15.54M | +407.5% |
| FY2022 | 2022-03-31 | 3.06M | +46.7% |
| FY2021 | 2021-03-31 | 2.09M | — |
Selling, General & Admin vs competitors
How AHG compares with its peers on the latest reported figures
- Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -58.4% is the lowest of 4, against a peer median of -25.7%.
- Selling, general & admin amounts to 24.6% of revenue for AHG, versus a peer median of 17.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CN¥1.8B CNY | -4.2% | -11.9% | 17.6% | |
ZKHZKH Group Limited | LTM Mar 2026 | CN¥1.15B CNY | -47.2% | -3.6% | 12.6% |
| LTM Mar 2026 | $88.24M USD | -25.7% | -28.1% | 43.4% | |
| LTM Mar 2025 | $3.64M USD | -58.4% | +6.0% | 24.6% | |
| Peer median (excluding AHG) | — | -25.7% | -11.9% | 17.6% | |
Competitors are the stored peer set for AHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Mar 2021 | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 |
|---|---|---|---|---|---|
| Revenue | 1.75M | 6M | 13.18M | 2.41M | 14.78M |
| Cost of Revenue | 544.57K | 5.39M | 11.91M | 2.29M | 15.06M |
| Gross Profit | 1.21M | 605.13K | 1.27M | 122.13K | (281.53K) |
| Gross Margin | 69.0% | 10.1% | 9.6% | 5.1% | -1.9% |
| Research & Development | 441.41K | 421.19K | 0 | 0 | 0 |
| Selling, General & Admin | 2.09M | 3.06M | 15.54M | 8.76M | 3.64M |
| Operating Expenses | 28.36M | 3.87M | 15.54M | 8.76M | 166.02M |
| Depreciation & Amortization | 15.16K | 18.39K | 18.39K | 8.64M | 2.15M |
| EBITDA | (28.9M) | (3.19M) | (14.27M) | (8.64M) | (1.77M) |
| EBITDA Margin | -1646.8% | -53.1% | -108.2% | -357.8% | -12.0% |
| Operating Income | (27.15M) | (3.26M) | (14.27M) | (8.64M) | (166.3M) |
| Operating Margin | -1547.1% | -54.3% | -108.2% | -357.8% | -1125.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.15M | 804.14K | 0 | 0 | 0 |
| Other Income / Expenses | 23.34M | (747.82K) | 1.2M | (453.75K) | 34.07K |
| Income Before Tax | (3.81M) | (4.01M) | (13.07M) | (9.09M) | (166.27M) |
| Pre-Tax Margin | -217.1% | -66.8% | -99.1% | -376.6% | -1125.1% |
| Income Tax Expense | 482.98K | 92.82K | 17.55K | 24.99K | (30.8M) |
| Net Income | (34.83M) | (16.85M) | (1.36M) | (9.46M) | (134.98M) |
| Net Margin | -1984.5% | -280.8% | -10.3% | -391.8% | -913.4% |
| EPS (Basic) | (0.26) | (2.55) | (0.06) | (0.45) | (0.48) |
| EPS (Diluted) | (0.27) | (2.55) | (0.06) | (0.39) | (0.48) |
| Weighted Avg Shares | 5.43M | 6.62M | 7.62M | 20.81M | 285.1M |
| Weighted Avg Shares (Diluted) | 5.43M | 6.62M | 7.62M | 23.83M | 285.1M |
Akso Health Group
NASDAQ:AHG
Intrinsic Alpha fair value
Locked
Current Price
$1.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.